Hypomethylating Agent Therapy for Chronic Myelomonocytic Leukemia Does Not Impact Acute Myeloid Leukemia Transformation or Survival

被引：0
|
作者：
Niyongere, Sandrine
Kathari, Yamini
Singh, Zeba
Vannorsdall, Emily J.
Emadi, Ashkan
Vu Doung
Baer, Maria R.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy
    J S Khorashad
    S K Tantravahi
    D Yan
    C C Mason
    Y Qiao
    A M Eiring
    K Gligorich
    T Hein
    A D Pomicter
    A G Reid
    T W Kelley
    G T Marth
    T O'Hare
    M W Deininger
    Leukemia, 2016, 30 : 2275 - 2279
  • [22] The Impact of PHF6 Mutations in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
    Chien, Kelly S.
    Kanagal-Shamanna, Rashmi
    Naqvi, Kiran
    Sasaki, Koji
    Alvarado, Yesid
    Takahashi, Koichi
    Kadia, Tapan M.
    Borthakur, Gautam M.
    Jabbour, Elias
    Routbort, Mark
    Pierce, Sherry A.
    Soltysiak, Kelly
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    BLOOD, 2019, 134
  • [23] Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy
    Khorashad, J. S.
    Tantravahi, S. K.
    Yan, D.
    Mason, C. C.
    Qiao, Y.
    Eiring, A. M.
    Gligorich, K.
    Hein, T.
    Pomicter, A. D.
    Reid, A. G.
    Kelley, T. W.
    Marth, G. T.
    O'Hare, T.
    Deininger, M. W.
    LEUKEMIA, 2016, 30 (11) : 2275 - 2279
  • [24] Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
    Castano-Diez, Sandra
    Alamo, Jose Ramon
    Lopez-Guerra, Monica
    Gomez-Hernando, Marta
    Zugasti, Ines
    Jimenez-Vicente, Carlos
    Guijarro, Francesca
    Lopez-Oreja, Irene
    Esteban, Daniel
    Charry, Paola
    Torrecillas, Victor
    Mont-de Torres, Lucia
    Cortes-Bullich, Albert
    Bataller, Alex
    Guardia, Ares
    Munarriz, Daniel
    Carcelero, Esther
    Riu, Gisela
    Triguero, Ana
    Tovar, Natalia
    Vela, Dolors
    Bea, Silvia
    Costa, Dolors
    Colomer, Dolors
    Rozman, Maria
    Esteve, Jordi
    Diaz-Beya, Marina
    ONCOLOGIST, 2024,
  • [25] Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia
    Courville, Elizabeth L.
    Wu, Yue
    Kourda, Jihen
    Roth, Christine G.
    Brockmann, Jillian
    Muzikansky, Alona
    Fathi, Amir T.
    de Leval, Laurence
    Orazi, Attilio
    Hasserjian, Robert P.
    MODERN PATHOLOGY, 2013, 26 (06) : 751 - 761
  • [26] Hypomethylating Agent Therapy and Survival Among Older Patients with Chronic Myelomonocytic Leukemia in the United States: A Large Population-Based Study
    Zeidan, Amer M.
    Hu, Xin
    Long, Jessica B.
    Wang, Rong
    Huntington, Scott F.
    Podoltsev, Nikolai A.
    Gore, Steven
    Ma, Xiaomei
    Davidoff, Amy J.
    BLOOD, 2016, 128 (22)
  • [27] Hypomethylating Agent Therapy Use and Survival in Older Patients With Chronic Myelomonocytic Leukemia in the United States: A Large Population-Based Study
    Zeidan, Amer M.
    Hu, Xin
    Long, Jessica B.
    Wang, Rong
    Ma, Xiaomei
    Podoltsev, Nikolai A.
    Huntington, Scott F.
    Gore, Steven D.
    Davidoff, Amy J.
    CANCER, 2017, 123 (19) : 3754 - 3762
  • [28] Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia
    Singh, Reema
    Halder, Rohan
    Verma, Megha
    Mehta, Pallavi
    Agrawal, Narendra
    Ahmed, Rayaz
    Bhurani, Dinesh
    BLOOD, 2022, 140 : 11713 - 11715
  • [29] Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia
    Arslan, Shukaib
    Zhang, Jianying
    Dhakal, Prajwal
    Moran, Jenna
    Naidoo, Nuthana
    Lombardi, Jennifer
    Pullarkat, Vinod
    Stein, Anthony S.
    Marcucci, Guido
    Yaghmour, George
    Bhatt, Vijaya R.
    Fathi, Amir T.
    Aldoss, Ibrahim
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (03) : E59 - E63
  • [30] Oral Azacitidine Maintenance Therapy in Acute Myeloid Leukemia after Frontline Hypomethylating Agent and Venetoclax
    Canavan, Cody
    Knight, Thomas G.
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Ai, Jing
    Levine, Jonathan K.
    Osei-Boateng, Kwabena
    Hiremath, Adarsh
    Grunwald, Michael R.
    BLOOD, 2024, 144 : 6036 - 6037
12345